Enhancing Radiation Therapy Response in Prostate Cancer Through Metabolic Modulation by Mito-Lonidamine: A 1H and 31P Magnetic Resonance Spectroscopy Study is a research paper published in International Journal of Molecular Sciences (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Institute for Translational Medicine and Therapeutics
Grant: ITMAT-UL1TR001878
Institute for Translational Medicine and Therapeutics
Grant: R01CA250102
Institute for Translational Medicine and Therapeutics
Grant: R01CA228457
Institute for Translational Medicine and Therapeutics
Grant: R01CA268601
Institute for Translational Medicine and Therapeutics
Grant: R21CA280523
NCI NIH HHS
Grant: R01 CA232433
NIH and University of Pennsylvania
Grant: R01CA250102, R01CA228457, R01CA268601, R21CA280523, and ITMAT-UL1TR001878
NCATS NIH HHS
Grant: UL1 TR001878
National Institutes of Health
Grant: 5R01CA250102-05
Melanoma: Metabolic Biomarkers of Response to Targeted Therapy
National Institutes of Health
Grant: 5R01CA268601-03
Metabolic Imaging of Targeted Therapies in Cancer
National Institutes of Health
Grant: 3UL1TR001878-06S1
Institutional Clinical and Translational Science Award
National Institutes of Health
Grant: 1R21CA280523-01A1
Translation of Noninvasive Metabolic Biomarkers to Targeted Therapy for Cancer
National Institutes of Health
Grant: 5R01CA228457-03
Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition
FWCI
0.00
Citation Percentile
0.0%
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals